DPT Vaccine Market – A market with high CAGR and return on investment by 2027

 DPT Vaccine Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.

The Global Diphtheria Tetanus and Pertussis (DPT) vaccine Market is growing exponentially owing to rising prevalence of chronic disease and increasing usage of combination vaccine and therapy are the major factor driving the DPT vaccine Market. Globally the market for DPT vaccine market is expected to grow at the rate of about 7.3% CAGR from 2016 to 2027.

Also Read : https://www.medgadget.com/2018/08/diphtheria-tetanus-and-pertussis-dpt-vaccine-market-will-exhibit-to-heighten-the-growth-by-2027-prognosticates-mrfr.html 

There is an increase in demand of diphtheria tetanus and pertussis vaccine across the globe and rising awareness regarding prevention of diphtheria, tetanus, and pertussis is major factors which are responsible for the growth of this market. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy.

Diverging product markets can be seen in preferences for traditional vaccines such as DTP. According to WHO, developed countries prefer to purchase a component of the DPT vaccines such as procure acellular pertussis (DTaP), while most developing countries purchase vaccines with whole cell pertussis (DTwP) components.

Regional Analysis for Global Diphtheria Tetanus and Pertussis (DPT) Vaccine Market

Globally, DPT Vaccine market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa.  North America is the largest market for Diphtheria Tetanus and Pertussis (DPT) vaccine.

The North American market for DPT Vaccine is expected to grow steadily over the forecasted period. This is due to the presence of high concentration of major market players in North America and its emphasis on vaccination against DPT. North American market consists of countries like the U.S., Canada and Mexico. Death rate sue communicable disease is seen to be growing, thus highlighting the importance of immunization. For instance, In March 2015 U.S FDA approved the use of Quadracel for immunization of children from 4 to 6 years of age. This was a great achievement for Sanofi helping it to maintain its leading position in the market.

Europe is the second-largest market for DPT Vaccine which is expected to grow at an overwhelming CAGR during the forecast period. This is due to increasing research and development activities by pharmaceutical companies and research institutes. The market is growing continuously in Europe as the key market players invested huge financial resources on research and development activities for the production of effective vaccines.  Increasing awareness about immunization of children against Diphtheria, tetanus and pertussis also drive this market in Europe.

Moreover, Asia Pacific is expected to be the fastest growing market for DPT Vaccine market. India is expected to be the emerging and fastest growing market. Presence of large patient pool drive this market in Asia-pacific. This region is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. Governments in developing countries of Asia-Pacific have undertaken various vaccinations programs. National Health Mission in India provide vaccination against diphtheria, pertussis, tetanus and polio.

The market shows steady growth in Middle East and Africa. In Middle East and Africa the demand for DPT vaccine is less than other regions across the globe.

Key Players for Global Diphtheria Tetanus and Pertussis (DPT) Vaccine Market

Merck & Co., Inc (U.S), Sanofi (France), GSK (U.S), Lanzhou Institute of Biological Products (China), Wyeth (U.S), Chiron Pharmaceutical Pvt Ltd (India), Serum Institute of India Pvt. Ltd. (India), Lanzhou Institute of Biological Products (China) and others are some of the prominent players at the forefront of competition in the Global DPT vaccine Market and are profiled in MRFR Analysis.

Global DPT vaccine Market – Company Analysis

Merck: Merck provides a wide range of vaccines which includes BCG USP, Pneumonix, Varivax, Pedvax HIB, Recombivax HB and others.

Sanofi: Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions, consumer healthcare, established prescription products and generics. Diphtheria and Tetanus Toxoids and acellular Pertussis Vaccine called Daptacel is the product offered by Sanofi which is the major market player.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dpt-vaccine-market-1357 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hospital Furniture Market to Witness an Outstanding Growth by 2023

 Hospital Furniture Market report by MRFR contains all analytical and statistical transient regarding Market summary, Growth, Demand and Forecast analysis with penetrating summary and solution within the complex industry.

Hospital Furniture Market is expected to reach at 9.8% CAGR during forecast period from 2019 to 2023, by research report from Market Research Future (MRFR). The global hospital furniture market is mainly driven by the growing demand from emerging economies to develop their healthcare sector and the increasing investment in the healthcare sector by private entities, leading to a growing demand for premium, expensive hospital furniture offering the latest in ergonomics and comfort. Growing Demand in India, China to Drive Hospital Furniture Market.

Also Read : https://www.medgadget.com/2019/10/hospital-furniture-market-growth-insight-trends-size-2019-global-share-new-development-key-country-analysis-and-forecast-to-2023.html

Hospital Furniture Market Competitive Analysis

Leading players in the global hospital furniture market include

• Beaver Healthcare Equipment,
• Moore Medical LLC,
• Renray Healthcare Ltd.,
• Bristol Maid Hospital Metalcraft,
• DRE Inc.,
• Anetic Aid Limited,
• KI,
• Bio Medical Solutions,
• Narang Medical,
• Hill-Rom,
• Chang Gung Medical Technology,
• GPC Medical Ltd.,
• The Brewer Company,
• Stryker Corporation

In September 2019, a new super-specialty ward is expected to open in the Government Medical College and Hospital in Aurangabad, India. Redevelopment of existing medical facilities is likely to pick up speed in India in the coming years, making it a leading regional market for hospital furniture and driving the global hospital furniture market over the forecast period.

Segments – Hospital Furniture Market

The global hospital furniture market is segmented on the basis of type into bedside tables, OT table, instrument stands, stretchers, hospital beds, chairs, scrub sinks, waste container, trolley and others.

On the basis of application, the global hospital furniture market is segmented into physician furniture, patient’s furniture, and staff’s furniture. Physician furniture is sub-segmented into examination table, surgery chair, and others. Patient furniture is sub-segmented into stretchers, bedside table, and other, while staff’s furniture is further segmented into stands and others.

On the basis of end users, the market is segmented into hospital, diagnostic centres, clinics and others. Hospitals hold the dominant share in the global hospital furniture market of 65% and are likely to remain the leading revenue generator in the global hospital furniture market over the forecast period.

Regional Analysis – Hospital Furniture Market

The Americas is likely to be the major revenue generator in the global hospital furniture market over the forecast period due to the growing demand for advanced hospital furniture in North America, especially the U.S. The growing presence of the private healthcare sector in North America is likely to be a major driver for the hospital furniture market in the Americas region over the forecast period. Private healthcare entities make more of an effort to pick the best furniture, to woo patients and new customers, whereas state-sponsored healthcare initiatives mainly pick hospital furniture based on utility rather than design or fashion. Thus, the strong presence of the private healthcare sector in North America is likely to be a major driver for the global hospital furniture market over the forecast period.

Europe is the second largest regional market for hospital furniture and is likely to hold on to a significant share in the global hospital furniture market over the forecast period. Europe is also home to several leading players in the healthcare sector, leading to a growing preference for expensive hospital furniture of a higher quality. The increasing efforts taken by the healthcare sector to engage and interact with patients in Europe are likely to be a key driver for the hospital furniture market in the region over the forecast period.

Asia Pacific is the third largest regional market for hospital furniture, and is expected to exhibit the fastest growth over the forecast period due to the growing demand from the increasingly well-funded healthcare sector in the region. The healthcare sector in developing APAC economies such as India and China has exhibited robust progress in the last few years due to the increasing government support and the increasing investment from private sector individuals. This is likely to result in an increasing demand for hospital furniture in the region over the forecast period, as several new hospitals are likely to be constructed in this region over the forecast period, as well as renovation and redevelopment efforts bearing fruit.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/hospital-furniture-market-1007 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Future Scope of Blood Glucose Test Strip Market is Witness to Grow High CAGR till 2023

 Blood Glucose Test Strip Market report focuses on the key player’s profiles in detail with granular analysis of the market share, production technology, market entry strategies, revenue forecasts and regional analysis of the market.

The global blood glucose test strips market is growing rapidly mainly due to the growing number of in diabetic patients, worldwide. Moreover, significant investments transpired into R&D to bring about improvements in the existing product line as well to develop new effective strips are escalating the market on the global height.

Acknowledging the continually ascending graph of the market growth, Market Research Future (MRFR) in its recently published study report asserts that the global blood glucose test strips market will garner the worth of USD 18.5 BN by 2020, growing at a CAGR over 6.2% throughout the review period (2015 – 2020).

Also Read : https://www.medgadget.com/2019/04/blood-glucose-test-strip-market-2019-opportunities-cagr-status-drivers-business-growth-and-forecast-to-2023.html

Drivers and Constraints Impacting the Market

Blood glucose test strips are self-testing strips which let pre-diabetic and diabetic people track their blood glucose level on a regular basis without visiting a diagnostic laboratory or a clinic. With the growing diabetic population, the global market for blood glucose test strip is considered to foster during the assessment period. For instance, as per the International Diabetic Federation, around 415 million people had diabetes in 2015. The number is estimated to reach 642 million by the end of 2040. Moreover, technological advancements such as accuracy of the tests along with awareness among the people regarding diabetes are stimulating the market growth.

On the flip side, product recall owing to the inefficiency of devices such as intense competition resulting in pricing pressure and false glucose reading are some of the major factors considered to impede the global blood glucose test strip market in the coming years.

Global Blood Glucose Test Strip Market: Segmental Analysis

The Blood Glucose Test Strip Market has been segmented on the basis of technology, distribution channel, and region.

By mode of technology, the global blood glucose test strip market has been segmented into optical, thin film electrochemical, and thick film electrochemical.

By mode of distribution channel, the global blood glucose test strip market has been segmented into retail pharmacy and hospital pharmacy. Among these, the hospital pharmacy is likely to dominate the global market and is anticipated to maintain its dominance over the assessment period. The growth is attributed to the increasing preference for self-care testing among the patients to monitor diabetes.

Regional Insights

Geographically, the global blood glucose test strip market span across regions namely, North America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, North America is presumed to lead the global blood glucose test strip market with $ 7.89 billion revenue. The growth is attributed to the extensive use of information technology coupled with high expenditure on healthcare. Moreover, the presence of major medical device manufacturers and high adoption of latest technologies are considered to stimulate the market during the review period.

Europe is estimated to hold the second position in the global market and is likely to maintain its dominance during the review period. High healthcare expenditure led by France and Germany is anticipated to drive the global market.

The Asia Pacific region is presumed to expand at a rapid pace owing to the presence of major regions such as India and China which are expected to lead the market due to unmet needs. This region is presumed to expand at 12.9 % CAGR owing to the growing number of diabetic population.

Industry Updates

January 2018: Ascensia Diabetes Care has recently announced the expansion of its strategic alliance with the Insulet Corporation which is a leader in tubeless insulin pump technology. The expansion follows the worldwide non-exclusive development agreement that Ascensia had announced in June 2017, to connect its CONTOUR NEXT ONE blood glucose monitoring system with Insulet’s next-generation Omnipod System.

Competitive Dashboard

The major players operating the global market are Apex Biotechnology Corp, Shanghai MicroSense, ALL Medicus, Beijing Yicheng Electronics, Elektronika, Nipro Diagnostics, Bayer Diabetes Care, B. Braun, LifeScan, ACON Laboratories, Jiangsu Yuyue, HMD BioMedical Inc., TaiDoc, Betachek National Diagnostics, Roche Diagnostics, i-SENS, Universal Biosensors, Abbott, SANNUO, AgaMatrix Inc, and others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/global-blood-glucose-test-strip-market-976 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Clinical Nutrition Market to See Incredible Growth During 2020 - 2027

 Global Clinical Nutrition Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.

Clinical Nutrition Market Highlights

Market Research Future reports say that the global clinical nutrition market would reach a higher valuation of its expected valuation by 2027. The predicted rate of growth for the market is mentioned to be substantial during the years from 2016 to 2027.

Also Read : https://www.medgadget.com/2020/02/clinical-nutrition-market-report-size-2020-global-industry-growth-research-study-development-pipeline-competitive-landscape-top-key-players-regional-revenue.html 

Top Market’s Drivers & Challenges

The study focuses on the fact that with the increasing aged population, the expenditure of clinical nutrition is estimated to rise in the future. Such a factor is framed to be an essential factor leading the market’s growth in the present years.

At the same time, due to the weak digestive framework at an old age, it becomes problematic for the human body to digest the required nutrients from food. Resulting from this, the loss of appetite is considered a significant issue due to which the elderly population does not get the necessary amount of nutrients. This is where clinical nutrition treatment is introduced. Such a factor has, therefore, become a key factor capitalizing the market of clinical nutrition treatment for the forecast period.

At present, clinical nutrition support is growing at a rapid pace. The global clinical nutrition market is going up with more factors such as high birth rate, a rise in the number of victims getting malnutrition treatment, and a high number of premature births. These have sored the use of clinical nutrition treatment and thus boosted its growth opportunities to the next level. All these factors have evolved as a vital factor causative to the growth of the market.

Furthermore, the study also reveals that the healthcare expenditure endures growing faster than economic growth in most of the countries, thus maintaining a trend observed over the decades. Therefore, as the healthcare expenditure increases in major countries of the world, the broader applicability of the treatment has provoked capitalized the market, which made it witness high growth in the forecast period.

Clinical Nutrition Market Segmentation

The analysis of the global clinical nutrition market has studied the segmental analysis, which included segments such as product types.

The product type segment thus includes infant nutrition—which further gets segmented among milk, soy, organic, others, and probiotic/prebiotic. The segment of enteral nutrition includes standard and for chronic illness as well as parenteral nutrition.

Clinical Nutrition Market Regional Outlook

The regional scrutiny of the global clinical nutrition market has been done over the key regions of North America, Europe, Asia– Pacific and The Middle East& Africa.

Among these regions, in 2014, North America held the position of the third-largest market for clinical nutrition products, by occupying 23.1% of the global market share. The U.S. leads the market in the North American region. The growth in consumer awareness about health and wellbeing, along with the swelling healthcare cost, is inspiring the demand for clinical nutrition products in the region. With this, the high birth rate is also one of the main drivers of the market in the region.

Asia-Pacific has the highest growth in the market, in comparison to the other regions. This is mainly due to high levels of malnutrition and the incidence of severe chronic diseases in the region. Thus, owing to the augmented metabolic disorders and rising income inequality in various countries, the region is also probable to by stand robust growth over the forecast period.

Clinical Nutrition Market  Key Players

The prominent key players that are involved in the Global Clinical Nutrition market are Hospira, Nestlé S.A, Abbott Laboratories, B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International, Inc, Mead Johnson Nutrition Company, GroupeDanone, Inc, Perrigo Company Plc and among others.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/global-clinical-nutrition-market-829 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dermal Fillers Market Poised to Witness a Significant Growth by 2025

 The exclusive research report on the Global Dermal Fillers Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

Dermal Fillers Market Outlook

The dermal fillers market has been witnessing continuous growth over the past few years. The strong consumer preferences to achieve a youthful appearance and look by reconstructing contour deformities in the face is a major driving force behind the growth of the market.  People are increasingly becoming conscious about their looks, and the dynamics of beauty are changing rapidly.

Also Read : https://www.medgadget.com/2020/03/dermal-fillers-market-report-2020-size-growth-share-trends-competitive-landscape-regional-analysis-with-global-industry-forecast-to-2025.html

Also, factors such as the influence of fashion, media & entertainment industry, and peer pressure for appearance & beauty encourage the adoption of dermal filling procedures. Looking at the growth in the dermal fillers market share, Market Research Future (MRFR) asserts that the global dermal fillers market size is poised to increase to USD 6,899.16 MN by 2025. In its recently published dermal fillers market report, MRFR also states that the market would register around 13.2% CAGR throughout the review period (2016 – 2022).

Also, the rapidly dropping dermal fillers cost and prices of dermal filler ingredients & lip fillers are substantiating the growth of the market. Owing to their non-invasive nature, dermal filling procedures are garnering massive popularity worldwide, which drives the dermal fillers market growth excellently. With the advances in medical science & technology, dermal fillers have evolved greatly, offering more than just supplements that increase facial volume and reduce wrinkles & folds.

There has been a significant rise in the number of treatments performed across the globe each year.  Subsequently, once considered as a part of the cosmetic surgery, dermal fillers treatments have now emerged as mainstream procedures. Rising demand for dermal fillers treatments alongside the developments in the facial rejuvenation industry fosters the market growth largely.

Additionally, factors such as the growing aging population and rapid urbanization are substantiating the market growth. Also, rapid increase in the global economy is impacting the market growth positively. Furthermore, the growing prevalence of obesity & accidents, alongside the increasing numbers of facilities & centers offering dermal fillers procedures and the safety margin, are the major tailwinds pushing the growth of the market. 

Global Dermal Fillers Market – Segmentations

The analysis has been segmented into three major dynamics.

By Type: Hyaluronic Acid, Polymers & Particles, Collagen, and others.

By Application: Lip Treatments, Face-Lift, Facial Line Correction Treatment, and others.

By Regions:  Europe, Americas, Asia Pacific, Middle East & Africa, and Rest-of-the-World.

Based on the application, Dermal Fillers Market is being segmented into lip treatments, face-lift, facial line correction treatment, and others. Dermal fillers can rejuvenate and restore a more youthful appearance by reconstructing contour deformities in the face. Dermal fillers can plump thin lips, increase shallow contours, and soften facial creases & wrinkles.

According to the data published by American Society of Plastic Surgeons (ASPS), lip treatments continue to be the gold standard in body shaping because of its versatility, efficiency, and effectiveness. Among other dermal fillers, applications, nose, and eyelid reshaping procedures have increased slightly over the last couple of years. Since the dermal filling is a non-surgical treatment, patients are now choosing among more options than ever before, particularly with nose and eyelid reshaping improvement.

Global Dermal Fillers Market   – Regional Analysis

North America holds the largest share in the global dermal fillers market. The market growth attributes to the high per capita expenses on healthcare & wellness and advances in medical science. Besides, factors such as the augmenting demand for cosmetic products, growing geriatric population, launches of new minimally invasive facial procedures, and rising clinical trials to innovate skincare products are substantiating the regional market growth.

US accounts for the largest market in the dermal filler market in North America. The uptake of dermal fillers procedure and spending in the field in the US is quite high, which support market growth. The North American dermal fillers market is expected to create a substantial revenue pocket over the assessment period, witnessing substantial investments in R&D activities and technologically advanced products.

Europe stands the second leading position in the global dermal fillers market. Rising per capita income is a key driving force behind the success of this market.  Additionally, the increasing acceptance of new aesthetic products & procedures and the demand for minimally invasive cosmetic procedures drive the growth of the regional market, excellently.

Also, growing government support for promoting the use of minimally invasive dermal procedures, increasing numbers of product approvals, and the availability of products across the region boost the market growth in the region. Countries such as Germany & France drive the growth of the regional market to an extent. The European dermal fillers market is estimated for exponential growth over the review period, heading with the huge uptake of new products & advanced therapies.

The Asia Pacific dermal fillers market has emerged as a promising market owing to the spreading awareness towards these aesthetic treatments and improving economic conditions that are improving the quality of life of people.  Besides, increasing geriatric population, rising per capita disposable income, augmenting demand for facial aesthetics products, and growing awareness about non-invasive cosmetic procedures available in the market foster the regional market growth.

APAC countries such as India, China, and Southeast Asian countries such as Vietnam, Malaysia, and Thailand, backed by are the major growth contributors to the regional market.  The APAC dermal fillers market is projected to witness a spurting growth over the next six years. 

Dermal Fillers Market   – Competitive Landscape

Highly competitive, the dermal fillers market appears to be diversified due to the presence of many players. Competing for a substantial market share, these players tap the growing markets for expansions. Innovation, mergers & acquisitions, collaboration, and brand reinforcement remain the key trends for leading players.

Rising cases of side effects or resistance are encouraging the players to focus on advanced products and procedures that can leverage minimal adverse effects. Simultaneously, growth opportunities in the market are encouraging these players to target emerging applications.

Major Players:

Players driving the dermal fillers market include Allergan (Ireland), Galderma Laboratories, LP (Switzerland), Merz Pharma (Germany), Sinclair Pharma (UK), Dr. Korman Laboratories (Israel), Teoxane Laboratories (Switzerland), SciVision Biotech Inc. (Taiwan), Suneva Medical (US), and Medytox (South Korea), among others.

Industry/Innovations/Related News:

January 08, 2020 —- AbbVie Inc. (the US), a publicly-traded biopharmaceutical company, announced the launch of a new global business – Allergan Aesthetics, onset of the completion of its acquisition of Irish-domiciled pharmaceutical company – Allergan plc. By the first quarter of 2020. Allergan Aesthetics would operate as a new global dedicated business with its own research & development function under the AbbVie umbrella, including aesthetic products, BOTOX Cosmetic, the JUVEDERM collection of dermal fillers, and COOLSCULPTING body contouring.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/dermal-fillers-market-3893 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Bone Graft Substitutes Market Estimated to Witness a Staggering Growth by 2027

 An expert on premium research reports, Market Research Future has added a report titled "Global Bone Graft Substitutes Market 2027" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Market Research Future (MRFR)’s latest study reveals that the Global Bone Graft Substitutes Market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027.The market is set to reach a valuation of USD 5,031 Mn by the end of the assessment period. Bone Graft Substitute Market information: by type (autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, others), by application (spinal fusion, joint reconstruction, long bone, dental, foot & ankle, others) – Global forecast till 2027  

Also Read : https://www.medgadget.com/2019/04/bone-graft-substitutes-market-2019-global-size-share-trends-competitive-analysis-growth-insights-by-2023.html 

Key Players – Bone Graft Substitutes Market

• Stryker Corporation,
• ACE Surgical Supply Company, Inc.,
• Dentium Co., Ltd.,
• Dentsply Sirona,
• Institut Straumann AG,
• BioHorizons IPH, Inc.,
• Medtronic plc, and
• Zimmer Biomet.

Bone Graft Substitutes Market – Overview

As per Market Research Future (MRFR)’s latest analysis, the global bone graft substitutes market is estimated to strike a CAGR of 6.52% over the forecast period 2017 to 2027. Autografts have been used for years to treat bone disorders. It is one of the extensively used surgical procedures for bone grafting. However, the pain associated with the surgery has led to the innovation of alternatives such as allografts, xenografts, etc. This, in turn, is projected to catalyze the expansion of the bone graft substitutes market in the forthcoming years.

The rising geriatric population has catapulted the orthopedic industry on an upward trajectory. It is likely to fuel demand for bone graft substitutes over the assessment period. Additionally, the growing demand for bone grafts from the dental care industry is expected to boost the proliferation of the market across the next couple of years.

The factors that are responsible for dictating the growth trajectory of the bone graft substitutes market during the projection period are high demand in military medical units, increasing orthopedic problems, rising need for reconstructive orthopedic treatments, etc. However, there are certain restraints in the market, which include the risk of disease transmission in allografts and xenograft, improper fixation and weak bonding, and risk of graft rejection.

Industry News:

In March 2018, Dentsply Sirona, a dental solution company, announced the acquisition of over OraMetrix, a provider of innovative 3D technology solutions for orthodontic care. The acquisition is a remarkable step towards the advancement of dental bone graft procedure.

In August 2018, Scandinavian orthobiologics company Bone Support received approval from Health Canada for Cerament G bone graft substitute.

In September 2018, Baxter International Inc., an American healthcare company, announced the receipt of FDA clearance for Actifuse Flow bone graft substitute to be used in orthopedic surgical procedures.

In November 2018, Bio2 Technologies, an orthopedic company, has received approval from FDA for evaluation of its Vitrium bioactive glass as a cervical interbody fusion device. Vitrium is currently in use as a bone graft.

Segments – Bone Graft Substitutes Market

Based on type, the global bone graft substitutes market has been segmented into autograft, demineralized bone matrix, synthetic bone grafts, bone morphogenetic protein, and others.

Based on application, the bone graft substitutes market has been segmented into spinal fusion, joint reconstruction, long bone, dental, foot & ankle, and others.

Regional Analysis – Bone Graft Substitutes Market

The global bone graft substitutes market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is the largest market for bone graft substitutes. The consolidation of major manufacturers in the region coupled with the swift uptake of novel technologies is likely to drive the growth of the bone graft substitutes market in the region. The U.S. is a significant country-level market of the region and is expected to contribute largely towards the development of the regional bone graft substitutes market in the forthcoming years.

Europe held the second-largest share of the global market and is poised to retain its potential through the assessment period. The factors that are contributing towards the growth of the market in Europe include rising awareness about bone graft substitutes, increasing healthcare expenditure, availability of funds for research & development, etc.

Asia Pacific is the fastest growing bone graft substitutes market and has been estimated to mark a CAGR of 6.85% during the forecast period. The developments in the fast-developing country-level markets such as India and China are inducing growth in the regional market. It is expected to exhibit a similar trend throughout the projection period.

The Middle East & Africa is set to witness steady growth over the next couple of years. Gulf nations, particularly, Saudi Arabia and the U.A.E. are primarily responsible for driving the growth of the bone graft substitutes market in the region.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/bone-graft-substitutes-market-1195

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

 

 

Global Human Growth Hormone Market is Expected to Experience Immense Growth During 2020 – 2023

 This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Human Growth Hormone Market over the forecast period.

The report titled as “Human Growth Hormones Market” Research Report implements an exhaustive study on MarketResearchFuture.com and This Report Cover market size, growth rate, market Dynamics and Factor Analysis. And also cover the other information such as Human Growth Hormones Market trends, Top players and Forecast till 2023.

Segments for Global Human Growth Hormones Market

The global human growth hormone market has been segmented on the basis of brand, application, route of administration, distribution channel, and region.

Also Read : https://www.medgadget.com/2019/09/human-growth-hormone-market-size-share-2019-global-analysis-by-growth-trends-drugs-key-players-region-with-global-industry-forecast-to-2023.html  

The market, based on brand, has been segmented into Genotropin, Humatrope, Norditropin, Omnitrope, Sainzen, and others. Among these, the Norditropin segment has been expected to account for the largest market share and is projected to record the highest CAGR of 11.81% during the assessment period

Based on the application, the market has been segmented into growth hormone deficiency, idiopathic short stature, Prader-Willi syndrome, small for gestational age, Turner syndrome, and others. The growth hormone deficiency segment has been assessed as the largest segment in terms of market value and is anticipated to grow at the highest CAGR of 7.07% during the forecast period.

On the basis of the route of administration, the market has been segmented into intramuscular, intravenous, subcutaneous, and oral. The subcutaneous segment has been assessed to record the highest market share the highest CAGR among the route of administration segment, and account for 39% of the market share during the forecast period.

Based on the distribution channel, the human growth hormone market has been segmented into clinics, e-commerce websites, hospital pharmacies, and retail pharmacies. The hospital pharmacies segment has been assessed to reach a valuation of USD 2,473.21 million, growing at the highest CAGR in this segment over the forecast period.

Based on the region, the global human growth hormone market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

Market Drivers

Market Research Future (MRFR’s) latest study reveals that the global market for human growth hormone will surge at an impressive CAGR of 7.50% during the review period (2018-2023). Growth hormone deficiency falls under the list of endocrine conditions. Growth hormone deficiency is prevalent across the globe and the reasons for the condition usually vary from person to person. Though the condition is rare, its prevalence rate has increased to a noteworthy level in recent times. In many cases, brain injury has been identified as a primary cause of growth hormones deficiency. Low level of growth hormone secretion can lead to altered body composition, osteoporosis, insulin resistance, lipid abnormalities, reduced energy levels, and reduced muscle strength. Low growth hormone secretion is usually an issue that starts at a young age and if not addressed promptly, may have major implications in later stages of life.

The human growth hormone (HGH) is an essential part of bodily functions and is one of the most important hormones produced by the pituitary gland in the human body and is responsible for the growth in infants and adults as well. The deficiency of the human growth hormone in the body can create severe repercussions, and in order to avoid the risks, medical professionals have now developed synthetically produced and administered human growth hormone.

Technological advancements in the healthcare sector along with rising investment in research and development, increasing awareness related to hormone therapy, and the growing prevalence of growth hormone deficiency are the factors influencing the growth of the global market for human growth hormone.

Competitive Analysis:

The players in the global human growth hormones market are aiming towards business expansion by increasing the research and development expenditure for introducing highly effective products in the global market. Increasing focus on strategic mergers and acquisitions is aiding the players in sustaining the competitive environment of the global human growth hormones market.

The key players identified in the global market for human growth hormone are Anhui Anke Biotechnology Co. Ltd., BioPartners GmbH, Eli Lilly and Company, Ipsen S.A., GeneScience Pharmaceuticals Co. Ltd., Genetech Inc., Lifetech Labs, Merck KGaA, Novo Nordisk A/S, Novartis AG, Pfizer Inc, and Zhongshan Hygene Biopharm Co. Ltd.

Regional Analysis for Global Human Growth Hormones Market

The Americas have been accounted for around 50% of the global human growth hormone market owing to the growing prevalence of the deficiency of the growth hormone, and Turner syndrome in the region. North America has been assessed to dominate the market share over the forecast period, due to the presence of advanced economies such as the U.S. and Canada, with established healthcare sectors and affordable hormonal therapy.

Europe is the second largest regional human growth hormone market, owing to the presence of significant market players, and favorable government initiatives towards superior healthcare facilities for the consumers.

The Asia Pacific is the fastest rising region in the global human growth hormone market and has been assessed to grow exponentially at a CAGR of 7.70% over the forecast period, owing to influential factors such as the increase in expenditure by the government towards healthcare sector to provide consumers with proper medical facilities. Additionally, international market players have expressed keen interest in contributing to the growing development in the Asia Pacific region by investing in the potential markets for various domains, including the regional market for human growth hormone.

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/human-growth-hormone-market-6494 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com